drugset / Trial / NCT02517502
Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of this study is to determine if a high dose of DHA begun prior to and continued during neo-adjuvant chemotherapy (chemotherapy given prior to surgery) is likely to prevent or lessen chemotherapy induced cognitive dysfunction.
Timeline
- Start
- 2015-07
- Primary completion
- 2017-09
- Completion
- 2019-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DHA | Unknown | 1600 mg | — |